We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFOR
976
Everforth Inc
EFOR
$1.37B
| $977K | ﹤0.01% |
11,723
-100
| -0.8% | -$9.13K |
|
977
iRhythm Holdings
IRTC
$4.06B
| $977K | ﹤0.01% |
10,839
+600
| +6% | +$47.1K |
|
|
APLS
978
DELISTED
Apellis Pharmaceuticals
APLS
| $976K | ﹤0.01% |
30,600
+3,000
| +11% | +$90.2K |
|
979
Liberty Live Group Series C
LLYVK
$9.92B
| $973K | ﹤0.01% |
+14,300
| New | +$909K |
|
980
Ameris Bancorp
ABCB
$6B
| $972K | ﹤0.01% |
15,530
| – | – |
|
|
PCH
981
DELISTED
PotlatchDeltic
PCH
| $971K | ﹤0.01% |
24,743
| – | – |
|
|
ESGR
982
DELISTED
Enstar Group
ESGR
| $962K | ﹤0.01% |
2,986
| – | – |
|
983
CRISPR Therapeutics
CRSP
$5.22B
| $960K | ﹤0.01% |
24,400
-4,700
| -16% | -$222K |
|
984
Bank OZK
OZK
$5.7B
| $959K | ﹤0.01% |
21,525
+700
| +3% | +$32K |
|
985
CNO Financial Group
CNO
$5.07B
| $958K | ﹤0.01% |
25,755
+3,100
| +14% | +$115K |
|
986
Synaptics
SYNA
$4.2B
| $957K | ﹤0.01% |
12,537
| – | – |
|
987
Ambarella
AMBA
$3.6B
| $956K | ﹤0.01% |
13,144
-1,000
| -7% | -$63.7K |
|
|
VSXY
988
Victoria's Secret
VSXY
$7.24B
| $954K | ﹤0.01% |
23,042
-1,700
| -7% | -$60.1K |
|
989
Rhythm Pharmaceuticals
RYTM
$7.99B
| $953K | ﹤0.01% |
17,021
-2,300
| -12% | -$127K |
|
990
Boise Cascade
BCC
$2.94B
| $951K | ﹤0.01% |
8,000
+1,300
| +19% | +$180K |
|
991
Granite Construction
GVA
$5.41B
| $951K | ﹤0.01% |
10,837
| – | – |
|
992
ACV Auctions
ACVA
$1.35B
| $950K | ﹤0.01% |
44,000
+2,500
| +6% | +$50.6K |
|
|
NSA
993
DELISTED
National Storage Affiliates Trust
NSA
| $948K | ﹤0.01% |
25,016
+2,100
| +9% | +$90K |
|
994
Envista
NVST
$4.51B
| $947K | ﹤0.01% |
49,100
| – | – |
|
995
Atmus Filtration Technologies
ATMU
$4.06B
| $944K | ﹤0.01% |
24,100
-900
| -4% | -$36.5K |
|
996
Scholar Rock
SRRK
$6.46B
| $942K | ﹤0.01% |
+21,800
| New | +$710K |
|
997
Zillow
ZG
$8.15B
| $942K | ﹤0.01% |
13,300
| – | – |
|
998
California Water Service
CWT
$3.1B
| $939K | ﹤0.01% |
20,724
+1,270
| +7% | +$64.1K |
|
999
Resideo Technologies
REZI
$3.1B
| $938K | ﹤0.01% |
40,700
+6,500
| +19% | +$152K |
|
1000
Steven Madden
SHOO
$3.46B
| $936K | ﹤0.01% |
22,003
+2,300
| +12% | +$104K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.